Palisade Bio (PALI) Stock Price
$0.943 0%
to add to portfolio
AI Score

-
Alternative
4 -
Fundamental
1 -
Technical
1
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Palisade Bio, AI stock picks, stock alerts and much more.
PALI AI Stock Analysis
AI stock analysis for PALI is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Palisade Bio (PALI) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Palisade Bio (PALI) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Palisade Bio (PALI), currently trading at $0.943, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PALI

-
Palisade Bio, Inc.
-
Symbol
PALI
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.6M
Similar Stocks
![]() |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
![]() |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
![]() |
Moderna MRNA |
$35.53 5.3% |
4 |
![]() |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
![]() |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
PALI Alternative Data
Web Traffic
Palisade Bio receives an estimated 2034 monthly visitors to palisadebio.com.
-
Web Traffic
2034
-
Change from Previous Month
5.9%
-
3 Month Change
3.7%
-
YoY Change
3.7%
News Mentions
Palisade Bio was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Palisade Bio has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
Twitter Followers
Palisade Bio has 1,817 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
1817
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
6.5%
Facebook Engagement
Palisade Bio has engaged 59 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
59
-
Daily Change
3.3%
-
1 Month Change
10.6%
-
3 Month Change
31.1%
LinkedIn Followers
1,851 are following Palisade Bio on LinkedIn, up by 3.6% over the last month.
-
LinkedIn Followers
1851
-
Daily Change
0%
-
1 Month Change
3.6%
-
3 Month Change
8.6%
Job Postings
Palisade Bio currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Palisade Bio has 15 employees.
-
LinkedIn Employees
15
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
PALI Financials
PALI Key Metrics
-
Total Revenue
$0
-
Net Income
-$3.5M
-
Earnings per Share
-$2.32
-
Free cash flow
-$3.1M
-
EBITDA
-$3.5M
-
EBITDA Ratio
0
-
Total Assets
$9.3M
PALI 2-year Revenue & Income
PALI 2-year Free Cash Flow
PALI Technicals
PALI SMA
PALI RSI
FAQ
What's the current price of Palisade Bio (PALI) Stock?
The price of an Palisade Bio (PALI) share is $0.943.
What's the market cap of Palisade Bio?
The current market cap of Palisade Bio is 2.6M.
Should I buy or sell PALI?
Palisade Bio exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Palisade Bio a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Palisade Bio stock. There are several bearish signals and market challenges that could negatively impact Palisade Bio's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Palisade Bio (PALI) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Palisade Bio stock right now, as the outlook appears bearish.
What are some stocks similar to Palisade Bio (PALI) that investors often compare it to?
Palisade Bio (PALI) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Palisade Bio's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Palisade Bio's stock price to be around $0.852 in 2026. Starting from the current price of $0.943, this represents a 9.7% change in price, indicating a bearish outlook for the stock.
How to buy Palisade Bio (PALI) Stock?
Palisade Bio stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Palisade Bio shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.